Bionano Amends $400M Shelf; Adds $3.9M Sold Under Prior Shelf and $148.1M Carry-Forward
BNGO sits 19% above its 52-week low of $1 on light trading volume (0.2× avg).
Summary
Bionano filed Amendment No. 1 to its $400M shelf, disclosing $3.9M of additional securities sold under its prior shelf and carrying forward $148.1M of unsold capacity. No new shares are being sold in this filing.
Key Events · Financing and Capital Events · BNGO
-
Shelf Amendment Adds Sold Securities
Amendment No. 1 to the $400M universal shelf discloses an additional $3,941,645.77 of securities sold under the prior shelf (File No. 333-270459) between the May 8, 2026 initial filing and October 30, 2026, with a $342.92 additional filing fee.
-
Carry-Forward of Unsold Capacity
$148,146,961.18 of unsold securities from the prior registration statement (effective May 10, 2023) is carried forward under Rule 415(a)(6); the prior shelf terminates on effectiveness of this one.
-
No Shares Sold in This Filing
The company is authorized to issue up to $400,000,000 of common stock, preferred stock, debt securities, warrants and units from time to time; any actual sale requires a prospectus supplement.
-
One-Third Float Cap Limits Raises
Under General Instruction I.B.6, sales in any 12-month period are capped at one-third of the $25,582,638.72 public float while it remains below $75.0 million; $5,944,305 was already sold under that instruction in the prior 12 months.
Analysis · BNGO · Industrial Applications And Services
This is Amendment No. 1 to the $400M universal shelf Bionano first filed on May 8, 2026, not a new capital raise. Two new facts matter: Bionano sold an additional $3,941,645.77 of securities under its prior shelf (File No. 333-270459) between the initial filing and October 30, 2026, and it is carrying forward $148,146,961.18 of unsold securities from that prior registration statement under Rule 415(a)(6). No shares are being sold now — the company is authorized to issue up to $400,000,000 of securities from time to time, and any actual issuance requires a future prospectus supplement. Against a going-concern warning reiterated in the Q2 10-Q (cash of $3.7M), the shelf is the mechanism Bionano needs to raise survival capital, and the $3.9M already sold shows it is drawing on it. The $400M headline vastly exceeds the company's roughly $16M market cap, so the practical constraint is the General Instruction I.B.6 limit: no more than one-third of the $25,582,638.72 public float in any 12-month period while the float stays below $75M.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BNGO was trading at $1.19 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $16.1M. The 52-week trading range was $1.00 to $2.23. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.